VERU Veru: Company Short-Term Debts

Symbol and logo of brand Veru Inc. (VERU)

Veru Inc. aims to redistribute cash flows from feminine hygiene products toward oncology drugs, a shift confirmed by short-term debt statistics. The current level stands at approximately 0.00, illustrating the company's liability dynamics. Revenues are based on cancer therapy and FC2 contraceptives; however, aggressive pressure from global pharma behemoths in the biotech sphere creates significant risks for the approval of new developments.

VERU Veru Inc Company Short-Term Loans and Borrowings (07/04/2022 - 10/30/2026)

VERU (Veru Corporation): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Veru|VERU - Consensus Target
- company stock capitalization data:
Market Capitalization Veru Inc.|VERU - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Veru|VERU - Accounting Value of Company|Market Cap to Net Assets Ratio verupharma.com|VERU - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Veru Inc.|VERU - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Veru Inc.|VERU - Company Aggregate Debts|Debt to Book Capitalization Ratio Veru Inc.|VERU - Company Long-Term Loans and Borrowings|Company Short-Term Debts Veru|Quick Liquidity Indicator verupharma.com
- earnings and multiples data:
VERU - Company Net Income
Analysis of all company metrics:VERU - Veru
Manufactured products of verupharma.com

Veru Inc. leverages significant pricing power driven by the uniqueness of enobosarm, allowing the company to effectively manage liquidity during patenting periods. Short-term liability dynamics on GURU.Markets reflect the speed of current obligation settlements, where debt reduction without a loss of revenue confirms financial stability and growing market confidence in the issuer's capital.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Current Liabilities CTOR (Citius Oncology, Inc.)|Company Short-Term Debt HURA (tuhurabio.com)|Company Short-Term Debts TARA (Protara Therapeutics, Inc.)|Fate Therapeutics Inc (FATE) - Short-Term Debt|WHWK - Company Short-Term Debt|Company Short-Term Loans and Borrowings TCRX (TScan Therapeutics)|CSBR (championsoncology.com) - Company Current Liabilities|XBiotech (XBIT) - Company Short-Term Debts|Company Current Liabilities CVM|OSTX: Company Short-Term Loans and Borrowings|Company Short-Term Debts RADX|Short-Term Debt Volume artivabio.com|Company Short-Term Debt Adlai Nortye ANL|TPST: Company Short-Term Indebtedness|Xilio - Company Short-Term Debts|Renovaro Inc. (RENB) - Company Current Liabilities|MURA (muraloncology.com) - Company Current Liabilities|KAPA - Short-Term Debt Volume|Company Current Liabilities OKUR|Company Short-Term Debt GDTC|Company Short-Term Debts CRIS|APLM - Short-Term Debt|Company Short-Term Debt Tharimmune Corp THAR|Company Short-Term Loans and Borrowings ADVB|GNPX: Company Current Liabilities|CLDI - Company Short-Term Debts|SBFM: Company Short-Term Debts|Company Current Liabilities Xenetic Biosciences, Inc.|SLRX (Salarius) - Company Short-Term Debts|Company Short-Term Debts Kitov Pharma|Company Short-Term Debt American Oncology Network (AONC)|beigene.com - Company Short-Term Indebtedness|Company Short-Term Debts CKPT (Checkpoint Therapeutics, Inc.)|ELEV - Company Current Liabilities|iCAD Corp - Company Short-Term Debts|Short-Term Debt Ikena Oncology, Inc.|Notable Labs, Ltd. (NTBL) - Company Short-Term Debt|Viracta Therapeutics, Inc. - Company Short-Term Loans and Borrowings|Company Current Liabilities MOR|NAYA: Company Short-Term Loans and Borrowings|Company Short-Term Debts AAPGV